Compton Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-27,990
Closed -$2.78M 145
2019
Q3
$2.78M Sell
27,990
-2,500
-8% -$238K 1.17% 24
2019
Q2
$2.82M Sell
30,490
-1,300
-4% -$123K 1.19% 26
2019
Q1
$3M Sell
31,790
-1,570
-5% -$137K 1.3% 21
2018
Q4
$2.14M Sell
33,360
-425
-1% -$31.4K 1.02% 33
2018
Q3
$3.02M Buy
33,785
+5
+0% +$442 1.19% 21
2018
Q2
$2.68M Buy
33,780
+1,100
+3% +$91.3K 1.13% 22
2018
Q1
$2.92M Buy
32,680
+250
+0.8% +$24K 1.24% 22
2017
Q4
$3.38M Buy
32,430
+5,270
+19% +$595K 1.44% 18
2017
Q3
$3.96M Sell
27,160
-2,200
-7% -$300K 1.78% 10
2017
Q2
$3.81M Hold
29,360
1.74% 10
2017
Q1
$3.65M Sell
29,360
-85
-0.3% -$10.2K 1.79% 11
2016
Q4
$3.41M Sell
29,445
-29,645
-50% -$3.3M 1.78% 11
2016
Q3
$6M Buy
59,090
+29,545
+100% +$3.2M 1.66% 13
2016
Q2
$2.91M Sell
29,545
-300
-1% -$31K 1.63% 15
2016
Q1
$2.99M Sell
29,845
-50
-0.2% -$5.15K 1.68% 16
2015
Q4
$3.58M Sell
29,895
-375
-1% -$43.4K 2.02% 10
2015
Q3
$3.27M Sell
30,270
-450
-1% -$55.8K 1.18% 11
2015
Q2
$3.56M Sell
30,720
-400
-1% -$45.7K 1.95% 11
2015
Q1
$3.59M Sell
31,120
-666
-2% -$79.6K 2% 11
2014
Q4
$3.56M Sell
31,786
-1,950
-6% -$206K 1.94% 12
2014
Q3
$3.2M Sell
33,736
-2,300
-6% -$208K 1.74% 13
2014
Q2
$3.1M Buy
36,036
+670
+2% +$51K 1.67% 13
2014
Q1
$2.47M Sell
35,366
-100
-0.3% -$7.92K 1.42% 17
2013
Q4
$3M Sell
35,466
-2,350
-6% -$186K 1.71% 13
2013
Q3
$2.91M Sell
37,816
-2,450
-6% -$172K 1.78% 12
2013
Q2
$2.35M Buy
+40,266
New +$2.42M 1.46% 15

Other funds holding CELG

Compton Capital Management's CELG Position: Q4 2019 in Review

Compton Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 27,990 shares — an estimated $2.78M sold.

Compton Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $6M in Q3 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Compton Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Compton Capital Management sold 27,990 Celgene Corp shares in Q4 2019, an estimated $2.78M.
  • Compton Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Compton Capital Management's Celgene Corp position peaked at $6M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Compton Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.